THE FEBRUARY ISSUE
OF GOLD IS HERE

Check out the new issue of GOLD! From the exodus of pharma marketers from Twitter to integrating artificial intelligence into medical affairs, this issue explores how the industry is evolving with changing environments for the benefit of customers and patients.

February 2023

Featuring insight from industry experts, this issue of GOLD reflects on pharma’s ambition to transform itself in the coming year and beyond, including insights from the NEXT Pharma Summit’s NEXT Normal event.

Topics include: 

Removing bias from AI
Digital key opinion leaders
Generational differences in HCP conversations
Neurological breakthroughs
A revealing conversation with Mina Makar, Senior Vice President, Global Cardiovascular, Renal and Metabolism, AstraZeneca

View and download

December 2022

Featuring insight from industry experts, this issue of GOLD reflects on the key issues the industry has faced in 2022, including insights from Reuters Pharma 2022 and FT Live’s Global Pharma and Biotech Summit.

Topics include: 

Health equity for transgender patients
Real-world data in rare diseases
Generics and biosimilars
An insightful conversation with John Wahba, Medical Head of the Global Digital Hub, GSK

View and download

October 2022

Featuring a host of insight from industry thought leaders, this issue covers the rise of alternative drug development models and treatments, the industry’s response to landmark legislation changes in the US, the rise and fall of biotech investment and much more.

Topics include: 

Non-drug treatments
AI in drug discovery
Pharma’s response to Roe v. Wade
A revealing conversation with Reshema Kemps-Polanco, Executive Vice President and US Head, Novartis Oncology